These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 19333002

  • 21. Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Sil A, Ravi MD, Patnaik BN, Dhingra MS, Dupuy M, Gandhi DJ, Dhaded SM, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Rout SP, Jayanth MV, D'Cor NA, Mangarule SA, Ravinuthala S, Reddy E J.
    Vaccine; 2017 May 19; 35(22):2999-3006. PubMed ID: 28449972
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L.
    Pediatr Infect Dis J; 2006 Aug 19; 25(8):706-12. PubMed ID: 16874170
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.
    Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Singh A, Gupta A, Chilkoti DC.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):2025-2031. PubMed ID: 28700282
    [Abstract] [Full Text] [Related]

  • 26. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
    Szenborn L, Czajka H, Brzostek J, Konior R, Caubet M, Ulianov L, Leyssen M.
    Pediatr Infect Dis J; 2013 Jul 02; 32(7):777-85. PubMed ID: 23838777
    [Abstract] [Full Text] [Related]

  • 27. Immunogenicity and Safety of a Liquid Hexavalent Vaccine in Indian Infants.
    Chhatwal J, Lalwani S, Vidor E.
    Indian Pediatr; 2017 Jan 15; 54(1):15-20. PubMed ID: 27889711
    [Abstract] [Full Text] [Related]

  • 28. A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age.
    Thollot F, Scheifele D, Pankow-Culot H, Cheuvart B, Leyssen M, Ulianov L, Miller JM.
    Pediatr Infect Dis J; 2014 Dec 15; 33(12):1246-54. PubMed ID: 25037033
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled study.
    Lalwani S, Chatterjee S, Chhatwal J, Verghese VP, Mehta S, Shafi F, Borys D, Moreira M, Schuerman L.
    Hum Vaccin Immunother; 2012 May 15; 8(5):612-22. PubMed ID: 22634448
    [Abstract] [Full Text] [Related]

  • 30. Safety and immunogenicity of diphtheria-tetanus-pertussis vaccine and hepatitis B vaccine as a new tetravalent combination (DTwP/HB) administered alone and at separate sites (DTwP and HB) including comparison with standard commercially available combination vaccine in Indian infants 6-14 weeks of age.
    Sharma HJ, Dutta AK, Joshi SM, Malik S, Bhardwaj S, Namjoshi GS, Parekh SS.
    Hum Vaccin; 2009 May 15; 5(5):310-4. PubMed ID: 18849664
    [Abstract] [Full Text] [Related]

  • 31. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
    Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D, HibMenCY-TT 005 Study Group.
    Pediatr Infect Dis J; 2010 Jan 15; 29(1):48-52. PubMed ID: 20035207
    [Abstract] [Full Text] [Related]

  • 32. Anti-HBs Titers Following Pentavalent Immunization (DTwP-HBV-Hib) in Term Normal Weight vs Low Birthweight Infants.
    Verma C, Faridi MM, Narang M, Kaur IR.
    Indian Pediatr; 2018 May 15; 55(5):395-399. PubMed ID: 29428913
    [Abstract] [Full Text] [Related]

  • 33. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.
    Int J Infect Dis; 2008 May 15; 12(3):278-88. PubMed ID: 17981067
    [Abstract] [Full Text] [Related]

  • 34. Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
    Vesikari T, Borrow R, Da Costa X, Richard P, Eymin C, Boisnard F, Lockhart S.
    Vaccine; 2017 Jan 11; 35(3):452-458. PubMed ID: 27939054
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F, Boisnard F, Thomas S, Sadorge C, Borrow R, PRI02C study group.
    Vaccine; 2017 Jun 27; 35(30):3764-3772. PubMed ID: 28583305
    [Abstract] [Full Text] [Related]

  • 36. A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months.
    Vesikari T, Becker T, Vertruyen AF, Poschet K, Flores SA, Pagnoni MF, Xu J, Liu GF, Stek JE, Boisnard F, Thomas S, Ziani E, Lee AW.
    Pediatr Infect Dis J; 2017 Feb 27; 36(2):209-215. PubMed ID: 27846055
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group.
    Pediatr Infect Dis J; 2006 Aug 27; 25(8):713-20. PubMed ID: 16874171
    [Abstract] [Full Text] [Related]

  • 38. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K.
    Int J Infect Dis; 2010 Jan 27; 14(1):e41-9. PubMed ID: 19467896
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
    Lee AW, Vesikari T, Gilbert CL, Klopfer SO, Schödel FP, Bhuyan PK.
    Vaccine; 2011 Oct 19; 29(45):7942-8. PubMed ID: 21875633
    [Abstract] [Full Text] [Related]

  • 40. Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed vaccines in Latin America.
    Macías M, Lanata CF, Zambrano B, Gil AI, Amemiya I, Mispireta M, Ecker L, Santos-Lima E.
    Pediatr Infect Dis J; 2012 Aug 19; 31(8):e126-32. PubMed ID: 22531237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.